D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 60 Citations 9,393 183 World Ranking 1388 National Ranking 27
Medicine D-index 71 Citations 14,698 322 World Ranking 14680 National Ranking 446

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Biochemistry

Kazuhiko Yanai spends much of his time researching Pathology, Histamine, Histamine H1 receptor, Internal medicine and Endocrinology. His research on Pathology frequently connects to adjacent areas such as Positron emission tomography. His research in Histamine is mostly focused on Histaminergic.

The concepts of his Histaminergic study are interwoven with issues in Orexin, Histamine H3 receptor, Histamine receptor, Neuroscience and Convulsion. His Histamine H1 receptor research includes elements of Doxepin, Anesthesia, Pharmacology, Antihistamine and Human brain. When carried out as part of a general Internal medicine research project, his work on Neuropeptide, Hypothalamus, Neurotransmitter and Dopamine receptor D3 is frequently linked to work in Leptin, therefore connecting diverse disciplines of study.

His most cited work include:

  • Psychosis pathways converge via D2high dopamine receptors. (280 citations)
  • Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors (263 citations)
  • 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease (254 citations)

What are the main themes of his work throughout his whole career to date?

Kazuhiko Yanai focuses on Histamine, Internal medicine, Pharmacology, Histamine H1 receptor and Endocrinology. His Histamine research integrates issues from Receptor, Histidine decarboxylase, Histamine H3 receptor and Histamine H2 receptor. His Pharmacology study focuses on Antihistamine in particular.

He has researched Histamine H1 receptor in several fields, including Histamine receptor, Doxepin, Human brain and Positron emission tomography. His Positron emission tomography research is multidisciplinary, relying on both Alzheimer's disease, Dementia and Nuclear magnetic resonance. Kazuhiko Yanai studies Endocrinology, namely Hippocampus.

He most often published in these fields:

  • Histamine (23.23%)
  • Internal medicine (21.51%)
  • Pharmacology (21.04%)

What were the highlights of his more recent work (between 2014-2021)?

  • Pathology (13.03%)
  • Histamine (23.23%)
  • Internal medicine (21.51%)

In recent papers he was focusing on the following fields of study:

Kazuhiko Yanai mainly focuses on Pathology, Histamine, Internal medicine, Positron emission tomography and Pharmacology. Specifically, his work in Histamine is concerned with the study of Histaminergic. His biological study spans a wide range of topics, including Fluorodeoxyglucose and Endocrinology.

His work deals with themes such as Heparan sulfate and Histamine H3 receptor, which intersect with Endocrinology. Kazuhiko Yanai interconnects Alzheimer's disease, Magnetic resonance imaging and Amyloid in the investigation of issues within Positron emission tomography. As a part of the same scientific family, he mostly works in the field of Pharmacology, focusing on Histamine H1 receptor and, on occasion, Histamine receptor, Antihistamine, Doxepin, Sedative and Cell biology.

Between 2014 and 2021, his most popular works were:

  • 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. (191 citations)
  • Propagation of pathological α-synuclein in marmoset brain. (91 citations)
  • [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease (86 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Biochemistry

His primary scientific interests are in Pathology, Alzheimer's disease, Positron emission tomography, Dementia and Nuclear medicine. His study in the fields of Amyloid under the domain of Pathology overlaps with other disciplines such as Germline mutation. His work on Tau protein as part of general Alzheimer's disease study is frequently linked to Biological property, bridging the gap between disciplines.

His study in Positron emission tomography is interdisciplinary in nature, drawing from both Frontal lobe, Neuroimaging and Enantiomer. Dementia is a subfield of Internal medicine that he explores. His research investigates the connection between Structure–activity relationship and topics such as Pharmacology that intersect with issues in Anesthesia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Psychosis pathways converge via D2high dopamine receptors.

Philip Seeman;Johannes Schwarz;Jiang Fan Chen;Henry Szechtman.
Synapse (2006)

371 Citations

Specific brain processing of facial expressions in people with alexithymia: an H215O‐PET study

Michiko Kano;Shin Fukudo;Jiro Gyoba;Miyuki Kamachi.
Brain (2003)

342 Citations

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease

Michelle T Fodero-Tavoletti;Nobuyuki Okamura;Shozo Furumoto;Rachel S Mulligan.
Brain (2011)

342 Citations

Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors

Isao Inoue;Kazuhiko Yanai;Daisuke Kitamura;Ichiro Taniuchi.
Proceedings of the National Academy of Sciences of the United States of America (1996)

325 Citations

2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients

Yukitsuka Kudo;Nobuyuki Okamura;Shozo Furumoto;Manabu Tashiro.
The Journal of Nuclear Medicine (2007)

303 Citations

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Hiroshi Toyota;Christine Dugovic;Muriel Koehl;Aaron D. Laposky.
Molecular Pharmacology (2002)

298 Citations

18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.

Ryuichi Harada;Nobuyuki Okamura;Shozo Furumoto;Katsutoshi Furukawa.
The Journal of Nuclear Medicine (2016)

293 Citations

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

Nobuyuki Okamura;Shozo Furumoto;Ryuichi Harada;Tetsuro Tago.
The Journal of Nuclear Medicine (2013)

279 Citations

Consensus group on new‐generation antihistamines (CONGA): present status and recommendations

S. T. Holgate;G. W. Canonica;F. E. R. Simons;M. Taglialatela.
Clinical & Experimental Allergy (2003)

268 Citations

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Nobuyuki Okamura;Shozo Furumoto;Michelle T. Fodero-Tavoletti;Rachel S. Mulligan.
Brain (2014)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kazuhiko Yanai

Agneta Nordberg

Agneta Nordberg

Karolinska University Hospital

Publications: 69

Pertti Panula

Pertti Panula

University of Helsinki

Publications: 63

Nobuyuki Okamura

Nobuyuki Okamura

Tohoku Medical and Pharmaceutical University

Publications: 58

Masahiro Ono

Masahiro Ono

Kyoto University

Publications: 54

Makoto Higuchi

Makoto Higuchi

National Institutes for Quantum and Radiological Science and Technology

Publications: 48

Philip Seeman

Philip Seeman

University of Toronto

Publications: 47

Hideo Saji

Hideo Saji

Kyoto University

Publications: 43

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 37

Seiji Nishino

Seiji Nishino

Stanford University

Publications: 35

Tetsuya Suhara

Tetsuya Suhara

National Institutes for Quantum and Radiological Science and Technology

Publications: 34

Christer Halldin

Christer Halldin

Stockholm County Council

Publications: 28

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 28

David J. Brooks

David J. Brooks

Newcastle University

Publications: 28

Pedro Rosa-Neto

Pedro Rosa-Neto

McGill University

Publications: 25

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 24

Alexander Drzezga

Alexander Drzezga

University of Cologne

Publications: 24

Trending Scientists

Patrick Kenny

Patrick Kenny

École de Technologie Supérieure

Naresh S. Dalal

Naresh S. Dalal

Florida State University

Chien M. Wai

Chien M. Wai

University of Idaho

Gaoping Cao

Gaoping Cao

Peking University

Yoshimichi Ohki

Yoshimichi Ohki

Waseda University

Vitor Sencadas

Vitor Sencadas

University of Wollongong

Eric A. Shoubridge

Eric A. Shoubridge

Montreal Neurological Institute and Hospital

Tapas K. Hazra

Tapas K. Hazra

The University of Texas Medical Branch at Galveston

Vincent Calvez

Vincent Calvez

Claude Bernard University Lyon 1

David R Gray

David R Gray

University of Tasmania

Chen-Feng You

Chen-Feng You

National Cheng Kung University

Hisato Iwata

Hisato Iwata

Ehime University

Gert-Jan de Bruijn

Gert-Jan de Bruijn

University of Amsterdam

Sarah S. Jaser

Sarah S. Jaser

Vanderbilt University Medical Center

Charles H. Hillman

Charles H. Hillman

Northeastern University

Tiinamaija Tuomi

Tiinamaija Tuomi

University of Helsinki

Something went wrong. Please try again later.